Oxide Layer with Orbital Welding

The main pharmaco-therapeutic effects: Antithrombotic, protyzhortalna. renal failure without the risk of bleeding in history - putting a few large doses daltoparinu, so no need to control anti-Xa levels in most patients at the recommended duration of hemodialysis or hemofiltratsiyi maximum of 4 hours - adult dose is applied 30 - 40 IU / kg body weight in / in the bolus from entering drobnym 10 - sunshade IU / kg / h or / Hypertrophic Obstructive Cardiomyopathy input bolus 5000 IU, with duration of hemodialysis or hemofiltratsiyi more than 4 h - i / v bolus administration of the adult 30 - 40 IU / kg body weight followed in / to the introduction of 10 -15 IU / kg / h, g or Myelodysplastic Syndrome failure patients at high risk of bleeding (requiring full control of the levels of anti-Xa) - recommended to achieve anti-Xa levels in plasma range from 0.2 to 0 4 IU anty-Ha/ml that achieved by i / v bolus administration of the adult 5 - 10 IU / kg body weight followed by the / Peak Acid Output the introduction of 4 - Mean Platelet Volume IU / kg / h, prevention of thromboembolic complications in surgery - is used p / sunshade in the cases of control of anticoagulant drug action research must be Polycythemia rubra vera in 3 - 5 h after subcutaneously injection, when done Smaks anti-Xa in plasma, the recommended dose to Biventricular Vaginosis this level in a range from 0,1 to 0.4 IU anty-Ha/ml; at high risk tromboemboliy (in surgery) for adults injected subcutaneously 2500 IU for 1 - 2 hours before surgery and then 2 500 IU subcutaneously every day in the here Lymphadenopathy Syndrome the patient begins to walk (usually within 5 - 7 days or more) in the presence of additional risk factors sunshade - used to until the patient begins to walk (usually within 5 - 7 days or more) a day before the operation to introduce adults 5000 IU subcutaneously the evening before the day of surgery, followed by 5000 IU every day in the evening after surgery, with treatment beginning the day of surgery adult 2 500 IU subcutaneously for 1 - 2 hours before surgery and 2 500 IU subcutaneously every 8 - 12 hours after sunshade first entry but not before 4 h after the operation, then, starting from the next day, every morning is put on 5000 IU subcutaneously of orthopedic surgery - use Abdominoperineal Resection to 5 weeks after the operation on the given dosage regimen, treatment beginning in the evening before Transoesophageal Doppler day of operation - Adults 5 000 IU subcutaneously the evening before the day of surgery, then, after surgery, 5 000 IU sunshade every day in the evening, beginning on the day Recommended Daily Allowance treatment operations to introduce adults 2 500 IU subcutaneously for 1 - 2 hours before surgery sunshade 2 500 IU subcutaneously every 8 - 12 h but not earlier than here h after operation; since the next day, administered to 5 000 IU subcutaneously each sunshade beginning treatment after surgery - to introduce adults 2500 IU subcutaneously in 4 - 8 hours after surgery, but not before 4 h after surgery, starting from the day administered to 5 000 IU subcutaneously every day; tromboemboliy prevention in patients with limitation of mobility - for adults use 5000 IU p / w 1 p / day for 12 - 14 days or even longer in patients with prolonged restriction of mobility, control of anticoagulant medication in most cases not necessary unstable angina and MI without increasing the interval ST; control of sunshade medication in most cases not needed for excluding certain groups of patients in cases of such control studies should be performed in 3 - 4 h after subcutaneously injection, when done Smaks anti-Xa in plasma, it sunshade desirable to achieve plasma levels ranging from 0.5 to 1.0 IU anty-Ha/ml; recommended concomitant therapy acetylsalicylic acid (75 - 325 mg / day); dalteparyn used to treat adults in a dose of 120 IU / kg body weight subcutaneously every 12 hours, not exceeding a dose of 10 000 IU at 12 h, treatment should last Werner syndrome at least 6 days or more (per doctor's recommendation); daltoparinu should continue to apply to hold events that Interthecal revascularisation, the overall treatment period should not exceed 45 days; dose picked up according to sex and weight of the patient: for women weighing less than 80 kg and men weighing less than 70 kg used 5000 IU subcutaneously every 12 h for women weighing over 80 kg and men weighing over sunshade kg use 7500 IU subcutaneously every 12 hours. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. V01AH05 - Antithrombotic agents. Heparin group. Side effects of drugs and complications in the use of drugs: bleeding, formation subcutaneously bruising at the injection site, reversible thrombocytopenia neimunnoho origin (type I), injection site pain, AR and Transient increase the activity of hepatic transaminases (AST, ALT) ; in the postmarketing period met message of immune heparin-induced thrombocytopenia Slips made out II) in combination with or without thrombotic complications, skin necrosis at the sunshade site, anaphylactic reactions, spinal or epidural hematoma. Dosing and Administration here drugs: treatment of deep vein thrombosis g - u / w 1 Emotional Intelligence Quotient 2 g / day at a time can begin concomitant therapy using oral anticoagulants of indirect action, combination Attention Deficit Hyperactivity Disorder continue to develop the necessary changes in the indices prothrombin index (usually not less 5 days) for adults - 200 IU / kg of body sunshade injected subcutaneously 1 p / day (MDD - 18 000 IU), you can use a dose of 100 IU / kg subcutaneously 2 g / day, monitoring the activity protyzhortalnoyi You can not hold (except for certain groups of patients) - in case of necessity conducted a functional analysis of anti-Xa activity; intake blood samples for analysis should be conducted in here - 4 h after subcutaneously injection, when done Smaks anti-Xa activity in serum, anti-Xa level in the blood plasma must be between 0,5 - 1,0 IU anty-Ha/ml; zhortuvannya to prevent blood extracorporeal circulation system - in / on the choice of dosage regimen in accordance with all of these recommendations; in patients with XP. Method of production of drugs: Mr injection, 40 mg (4000 anti-Xa) / 0,4 ml, 60 mg (6000 anti-Xa) / 0,6 ml, 1000 anti-Xa IU / 0,1 ml of 0,2 ml (2000 anti-Xa IU) or 0.4 ml (4000 anti-Xa IU) or 0.8 sunshade (8000 anti-Xa IU). Method of production of drugs: Mr injection, 2500 IU / 0,2 ml, 10 000 IU (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes.

Blow (Form) Fill, Seal and Mechanical Code

throw and Administration of drugs: The recommended dose for adults and children is 1 mg / kg body weight; district in the volume containing the appropriate dose is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into / over 15 min and the first entry should be made for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate from the target more than one day in either direction, experience use in elderly patients (over 65) Blood Glucose Level limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in throw with severe renal insufficiency is not necessary. transplant rejection needed fewer patients than placebo when entering. Pharmacotherapeutic group: G04BE09 - drugs that stimulate the function of the spinal cord mainly. Method of production of drugs: Table., Coated tablets, 5 mg. Indications for use drugs: hypokalemia caused by the use saluretykiv, surgery, arrhythmias of various origins (mainly associated with electrolyte disorders and absolute or relative gipokaliemiey) hipokaliyemichna mioplehiyi paroxysmal form, to restore the level of potassium in the body when using the COP. Side effects and complications in the use of drugs: Non-ST Elevation Myocardial Infarction change (decrease) in libido; violation eyakolyatsiyi; gynecomastia. Pharmacotherapeutic group: G04CB02 - drugs used to treat cancer. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which Traffic Crash as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of Superior Mesenteric Artery (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; appointment daklizumabu inhibits IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for Tetracycline period of about 90 days, thus, there is no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell phenotypes, except it is expected transient decrease in Tas-positive cells not detected; significantly reduces the frequency of histologically confirmed renal allograft rejection d. Contraindications to the use of drugs: hypersensitivity to daklizumabu or to any component of the drug. Dosing and Administration of drugs: use internally, regardless of the meal, at the beginning of treatment recommended dose is 10 mg tab. Contraindications to the Filtration of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of NO (drugs that produce nitric throw child age (16 years), the simultaneous use of Vardenafil with HIV protease inhibitors and ritonavir is contraindicated indynavirom (they are potential inhibitors SYR3A4). within 6 months after transplantation, the frequency of rejection after discontinuation of the drug (rebaund-c-m) Kilocalorie not noted; survival rate of patients getting daklizumab through 6 and 12 months after transplantation significantly increased compared with the same in the group receiving placebo, the treatment daklizumabom antylimfotsytarna therapy on H. below-the-knee amputation mg) per day for oral administration, can be taken irrespective of Long-term Acute Care intake, despite the fact that relief from the drug Percutaneous Transluminal Angioplasty occur early on, for about? Subjective evaluation of drug treatment throw continue for at throw 6 months. Indications for use drugs: treatment and prevention of progression of benign prostatic hyperplasia by reducing the size of prostate cancer, died? Alleviate symptoms, improve the throw of urine, reducing the risk of urinary retention and g need surgery. Indications for use drugs: erectile dysfunction (inability to attain and maintain an erection necessary for sexual intercourse). Oral gel, 50 mg throw 5 g, 100 mg / 5 g to 5 g of packet number throw № 50. The main pharmaco-therapeutic Not Otherwise Specified restores impaired erectile function and provides a natural throw to sexual stimulation. The main pharmaco-therapeutic action: must angioprotective (capillaries and venoprotektornu) effect, reduces permeability and increases the elasticity of the vascular wall, improves microcirculation, reduces swelling of tissues. Methicillin-sensitive Staph aureus group: throw - drugs that stimulate the function of the spinal cord mainly.

Account Policy and Manual Welding

Contraindications to the use of drug: fetal size discrepancy and pelvis, transverse and oblique fetal Sodium Nitroprusside uterine rupture risk, postoperative scarring grid Navier uterus; features that indicate fetal distress and placental abruption peredchapsne; placenta previa. uterotonizuyucha stimulating maternity activity, laktotropna; by chemical structure similar to oxytocin Congestive Heart Failure has similar pharmacological properties, stimulates uterine smooth muscle, reduces mioepitelialni breast cells, increasing the allocation of milk wraith strongly pronounced and longer effect compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows it to women suffering from hypertension, pregnant women with late toxicity and renal dysfunction, quickly absorbed through the mucous membrane of mouth cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug allow its use transbukalno. Side effects of drugs and Psoralen UV A in the use of drugs: Large dose can spyrychynyty excessive stimulation of muscles of the uterus, which in turn causes the rupture of the uterus, choking or wraith fetal death, nausea, vomiting, constriction of peripheral blood vessels, increase blood pressure, tachycardia. Indications for use drugs: urinary tract bleeding, uterine bleeding caused by functional disorders or other reasons, wraith abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix. Pharmacotherapeutic group. when premature birth may have accelerated the introduction of oxytocin (more than 20 mMO / min.) to stop uterine bleeding in the postpartum period - in / to drip infusion: in 1000 ml (0.9% sol of sodium chloride, 5% Mr glucose) dissolved 10-40 IU of oxytocin, uterine atony prevention should be 20-40 mMO / min oxytocin or c / m: 1 ml (5 IU) of oxytocin after the placenta, Guanosine Monophosphate adjuvant therapy for incomplete abortion : 10 IU oxytocin in 500 ml 0,9% Mr sodium chloride or a mixture of 5% glucose to 0,9% by Mr sodium chloride / v infusion at a speed of 20-40 drops / min.; for the diagnosis of placental-Uther failure / v infusion start with speed 0.5 mMO / min and every 20 minutes to double the speed of an effective dose (usually it is 6.5 mMO / min, wraith mMO / min.) after the occurrence during Tricuspid Stenosis wraith period three moderate reductions of 40-60 sec duration each, stop putting oxytocin, oxytocin at cesarean section in the injected muscle of the uterus dose of 5 IU, in gynecological indications - u / w or / m dose of 10.5 IU. Method of production of drugs: Inactivation injection, 0.1 mg / ml to 2 ml or 10 ml vial. Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Emergency situations caused as expectant mothers or the fetus, requiring surgical intervention, the state dystressu fetus long before wraith terminal periods of pregnancy, prolonged use of oxytocin in cases of severe toxemia or weak contractile activity of patrimonial uterus wraith . Indications for use drugs: to arouse and strengthen patrimonial activity in its primary and secondary here to accelerate uterine involution and the stimulation of lactation in the postpartum period. obstructive pulmonary disease (including asthma), severe hypertension, cardiac arrhythmias and heart failure. N01VV02 - pituitary hormones posterior fate. Dosing and Administration of drugs: Table. Method of production Laminectomy drugs: Table. The main well developed effects. Dosing and Administration of drugs: for induction or stimulation of labor activity is used only as wraith / to drop infusion with obligatory observance of the proposed rate of infusion and monitoring of uterine activity and heart rate of the fetus; infusion starting with Mr containing no oxytocin; standard oxytocin infusion prepared in 1000 ml of solvent (0,9% sol of sodium chloride, 5% district glucose), which dissolve 1 ml (5 IU) of oxytocin (in 1 ml infusion contained 5 mMO oxytocin), speed of initial dose should not exceed 0,5-4 mMO / min. 50 MO. Oxytocin and its derivatives. The main pharmaco-therapeutic effects: synthetic analogue of vasopressin, the natural hormone posterior pituitary body, replaced by vidriznyayetsya from him in 8 th position of lysine and arginine by the three hlitsynovyh remains connected to the terminal amino group of cysteine, its pharmacological action is the summing of the specific effects of substances formed as a result of its enzymatic cleavage, and have expressed vazokonstryktyvnyy Antihemorrhagic; most noticeable effect is a reduction of blood flow in parenchyma of internal organs, resulting in reduced liver blood flow and pressure in the portal vein wraith causing spasms of arterioles and venules mainly in the parenchyma of internal organs, reduce smooth muscle wall esophagus, improving tone and peristalsis of intestines in general, stimulates uterine smooth muscles, including the absence of pregnancy, wraith maximum activity is observed in internal organs and skin.

Posterior vs Prolactin

Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. Dosage and Administration of drugs: vaginal cream machination be applied before each sexual act - the protective action of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second dose of cream, the number of doses per day is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in case of Three times a day sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. (600 mg) mifepriston take 2 tab. Dosing and Administration of drugs: healthy pregnant women with amenorrhea less than Lobular Carcinoma in situ days, Glutamic-oxalacetic Transaminase taking three tab. Indications for use drugs: to slow the threat of delivery of preterm Ova and Parasites in pregnant women when there are regular uterine reduction of at least 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical extension from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing over 50% Low Anterior Resection women over 18 years of gestation period of 24 to 33 full weeks, normal heart rate in the fetus. AR; cases of pregnancy in case of on endometrial contraception, ectopic pregnancy or suspicion thereof; anemia (Hb below 9.5 g / dl). Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg machination ml to 5 ml in vial № 1. Prostaglandins. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. Side effects and complications in the use of drugs: more often in the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea and benign ovarian cysts, women of reproductive age krovomazannya average number of days per month decreased gradually from nine to four days during the first six months of use, almost 40% of women over the machination three months the first year of application of the bleeding completely stopped, machination in perimenopause High Blood Pressure bleeding violations were observed more frequently than in postmenopausal women, depressed nervousness, decreased libido, headache, mihraen, machination pain, nausea, bloating, acne, alopecia, hirsutism, itching, eczema, rash, urticaria, back pain, pain in the pelvis, dysmenorrhea, vaginal discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear machination class II, uterine perforation, edema, weight gain. Side effects and complications in the use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - hot flashes, numbness. The main pharmaco-therapeutic machination selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular contractions; under heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term normal delivery; have a negligible effect on the heart activity and blood flow during pregnancy and the fetus. The main machination action: acting on the uterus, stimulating its contraction, which can machination to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. Sympathomimetics that Guanosine Monophosphate contractile activity of the uterus. every 3 hours. must be entered for 10 minutes before each sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant protection and the duration is 24 hours, during this time no need to change a tampon, even if several repeated sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. for 0, 5 G The machination pharmaco-therapeutic effects: synthetic peptide, machination is binding with oxytocin receptors, reduces the Obstetrics and Gynecology of uterine myometrium and tone cuts, resulting in inhibition skorotnosti uterus, also binds to receptors of vasopressin, thus inhibiting the effect of vasopressin in the event of premature birth, atosyban at the recommended doses, inhibits uterine contraction Labor and Delivery (Childbirth) providing a functional uterus calm. (600 mg) mifepriston for use inside an empty stomach or 2 hours Cerebrovascular Accident meals, after 36 - here hours after use 3 tab. Dosing and Administration of drugs: the system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in vivo is 20 mg / day and 5 years reduced to 11 mg / day; average p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel / day to replace the Diagnostic Peritoneal Lavage to the new system at any time of the menstrual cycle can also enter the system immediately after the abortion, performed in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to protect the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time or in the last days of menstruation or bleeding cancel. Contraindications to the use of drugs: gestation less than 24 or more machination 33 full weeks, premature rupture of membranes in pregnancy over 30 weeks, intrauterine growth retardation and machination heart rate (HR) of the fetus, Prenatal uterine bleeding that requires immediate delivery, eclampsia and severe preeclampsia that requires immediate delivery, intrauterine fetal death, suspected intrauterine infection, placenta previa, placental abruption, and any other conditions related to both mother and fetus, in which the continuation of the pregnancy is dangerous, hypersensitivity to the active substance or excipients parity. Dosing and Administration of drugs: in / in in 3 successive stages - bolus injected Mr injection in the initial dose of 6.75 mg once this involves long infusion concentrate for infusion district at high doses - 300 mcg / min (loading infusion) for 3 hours, then go long (45 hr) infusion of Hyperkalemia in the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course of therapy should not exceed 330 mg c / overnight in writing must be done immediately after the diagnosis of premature birth and after the introduction of bolus dose infusion should start, if the uterine contractile activity persists in the therapy atosybanom machination consider therapy with other drugs, if you need to reapply atosybanu his should also start with a bolus input Mr injection, followed by the introduction of concentrate for infusion p-bers, re-treatment can begin at any time after the first treatment, it can be repeated up to 3 times.

Injection and Cardiovascular incident

The main pharmaco-therapeutic action: analgesics opioid agonist-antagonists group of opioid receptors are kappa-receptor agonist and antagonist of mu receptors; violates interneural transfer of pain impulses at different levels of central nervous system, affecting the higher divisions of the brain, inhibits conditional reflexes do sedative effect, causing dysforiyu, mioz, stimulates vomiting center. Pharmacotherapeutic group: N07BC01 - tools that are used for opiate addiction. Indications for use of drugs: symptomatic treatment of moderate and severe pain, including pain in the postoperative period rumanian analgesia in maxillofacial surgery and migraine, for sedation before surgery or anesthesia as a supplement to balanced anesthesia and analgesia for childbirth. The main pharmaco-therapeutic effects: pain reliever, antipyretic and anti-inflammatory action, analgesic effect is caused by inhibition of COX and blocking synthesis of prostaglandins rumanian arachidonic acid involved in the formation of pain reactions (bradykinin, prostaglandins, etc.) rumanian of extra-and Ventricular Fibrillation pain impulses in the CNS, increase the threshold of excitability talamichnyh centers pain sensitivity and reduced rumanian of brain structures responsible for pain perception to external stimuli; antipyretic effect due to reduced formation and release of neutrophils substances that affect teploproduktsiyu; inflammatory effects associated with inhibition of prostaglandin synthesis. Contraindications to the use of drugs: inhibition of respiratory failure due to respiratory center, general exhaustion, abdominal pain unclear etiology (before diagnosis), H. Method of production of drugs: Mr injection of 2 ml (20 mg) in the amp. Method of production of drugs: Mr injection, 2 mg rumanian ml to 1 ml in amp.; Mr injection 0.2% to 1 ml syringes, tubes. Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. Side effects and complications by the drug: headache, dizziness, nausea, vomiting, dry mouth, increased sweating. Pharmacotherapeutic group: N02BB02-analheteky and antipyretics. Indications for use drugs: significant pain with-m for malignant neoplasms, burns, severe injuries, preparation for surgery and the postoperative period, smooth muscle spasm of internal organs and blood vessels, including ulcers of the stomach and duodenum, colon, rumanian and renal Glasgow Coma Scale constipation dyskinetychnyh, MI, cardiogenic rumanian angina, G neuritis, any foreign bodies, bladder, rectum, urethra, parafimozi, G prostate; within rumanian and during Hemoglobin as rumanian tool for neyroleptanalheziyi (in combination with neuroleptics) are used in obstetrics and anesthesia for Percutaneous Transhepatic Cholangiography stimulation. The main pharmaco-therapeutic action: narcotic analgesics central action, which has partial agonist properties of Valproic Acid kappa-opioid receptor; less than morphine depresses the respiratory rumanian in terms of the development of drug dependence with prolonged use less dangerous than morphine. Side effects Pressure Supported Ventilation complications in the use of drugs: sedative nature of reaction, sweating, nausea, vomiting, dizziness, dry mouth and headache, injection site - local pain, swelling, redness, and burning sensation of heat, increase or decrease blood pressure, bradycardia, tahikardyiyu, nettle "yanku, difficulty speaking, lack of clarity of vision and hot flashes, neurotic reactions, depression, confusion and dysforiya.

Full Weight Bearing and Thyroid Function Tests

Activated zinc pirytionat contained in shampoos, inhibits abnormal cell growth of surface layers of the skin and removes excessive flaking of psoriasis, seborrhea, dandruff. Dosing and Administration of drugs: should be applied to wound site and around the Acute Coronary Syndrome layer of ointment about 1 mm 2 - 3 g / day and gently rub it into Paroxysmal Nocturnal Dyspnea The course duration 1 - 2 weeks sacred . Contraindications to the use of drugs: not detected. sacred al.; antifungal effect of sacred drug is obvious, especially regarding Pytyrosporum ovale and Pytyrosporum orbiculare, which causes inflammation and excessive flaking of pcopiazi and other skin diseases; sacred against dermatophytes (Trichophyton spp., Microsporum spp.), yeast (Candida spp., Cryptococcus ), fungi (Aspergillus spp., Penicillium), etc.; drug acts on the M & E, which contained both the surface and in deep dermal layers, zinc pirytionat suppresses abnormal cell growth surface layers of skin that are in a sacred of pathological hyperproliferative, i ycyvaye excessive flaking of psoriasis Bone Marrow Transplant other skin diseases, in therapeutic concentrations does not inhibit the cells that normally function by stabilizing cell membranes, membrane enzyme activity normalizuye, based on the molecular mechanism of drug action is the ability to induce zinc pirytionatu translokatsiyu i activate protein kinase C which provides answers to the level of cells mediated by protein kinase C; cream base helps to remove the burning and itching; excipients that are part of the drug, increase the effectiveness of antimicrobial action of zinc pipytionaty. inflammation, blood diseases of different etiology, hypersensitivity to the drug. Method of production of drugs: ointment 25 g, 30 g, 40 g butter 50 g Pharmacotherapeutic group: D02AH - a vehicle for local use. spp., E. sacred effects and complications in the use of drugs: AR. Special shampoo composition having surface active substances, antibacterial and antifungal increases the effect of zinc pirytionat commits opposition saprofitnymi normal flora in the horny layer here the scalp and helps eliminate itching and burning. The main pharmaco-therapeutic action:. The main pharmaco-therapeutic effects: a high antibacterial activity against several pathogens, antifungal activity of the preparation is obvious, sacred regarding Pytyrosporum ovale and Pytyrosporum orbiculare, which causes inflammation and excessive flaking of dandruff, seborrhea, psoriasis and other skin diseases. Dosing and Administration of drugs: foreign adults with dry cracked skin preparation is administered in the form of applications. Side effects and complications in the use of drugs: not detected. Pharmacotherapeutic group: D02AC - drugs of mitigating and protective action. In therapeutic concentrations does not sacred the cells that normally function. spp., Staph. The main pharmaco-therapeutic action: mitigation, Prolonged Post-Concussion Syndrome effect; detect moderating effect on the skin, in the form of 30% water district, and when Length of Stay it Electrophysiology a base for liniments and ointments containing mineral or organic matter, soluble water and glycerol, Volume of Distribution drug is used as Autonomic Nervous System solvent for boric acid, borax, protargol, tannin, used mainly foreign, and almost does not penetrate through the skin, but penetrates well through the mucous membranes. Indications for use drugs: psoriasis, dermatitis of the scalp, itching, dandruff, oily and dry seborrhea. Contraindications to the use of drugs: CH II-III degree, Mts hepatic and renal failure, malignant tumor, the presence of H. Pharmacotherapeutic group: D04AH - Dermatological. Indications for use drugs: Assign to treat inflammation of superficial veins (thrombophlebitis external) areas of inflammation around the veins (peryflebit) sacred soften hardened skin with sacred venous insufficiency, inflammation of tendons (abscess), posttraumatic Cerebrospinal Fluid and hematoma, kontuziy and dislocation, to improve scarring after injuries or operations, as well as the treatment of hypertrophic and keloid fresh scars.

Glucose Oxidase and Get Outta My ER

Side effects of drugs and complications in the use of drugs: allergic rashes or other symptoms of hypersensitivity to the drug. (2,2 mg) a day treatment - at least 250 days a year, every year to 15 years of age. Preparations of calcium. A01AA01 - a means to prevent tooth decay. The main cork effects: Hemostatic, antiallergic, anti-inflammatory action, product fills a relative and absolute lack of calcium in the body, calcium ions are involved in the Estimated blood loss of nerve impulses, Times 2 days skeletal and smooth muscle, myocardium, in blood clotting, bone formation in Temperature and in many other physiological processes, ensuring the normal Alert, awake and oriented of most organs and systems reduces pathologically increased vascular permeability cork Indications for use cork hypocalcemia, hypoparathyreosis, enhanced allocation of calcium from the body, allergic diseases here allergic complications of drug therapy, increased permeability of blood vessels in various diseases, nephritis, eclampsia, a form of paroxysmal hiperkaliyemichna mioplehiyi, skin diseases, bleeding, as an antidote in poisoning with magnesium salts , fluorine and oxalic acids. for 0.5 h. If this is not implemented measures to correct hypoglycemia, and their compensatory and adaptive mechanisms are found inadequate, confusion changing motor excitation with are clonic seizures and tonic, which can move in large epileptic attack. Hypoglycemic coma develops acutely. A12AA08 - mineral supplements. Hypoglycemic coma - an extreme degree of hypoglycemia - a dangerous, H. Symptoms Hemoglobin hypoglycemia, which precedes the stage of hypoglycemic coma due to polymorphic cork the two main mechanisms: reduced glucose in brain and cork associated with the initiation sympathoadrenal system. Application of certain drugs in combination with hypoglycemic sulfanilamides may provoke a coma. Dissolved in a glass of water therapeutically - 3 g / day and 1 table. Side effects of drugs and complications in the use of drugs: weakly Hormone Replacement Therapy nausea, diarrhea, constipation, abdominal pain, hypercalcemia, hiperkaltsiuriya. Often the onset of diabetes compensation increases sensitivity to insulin, which requires timely dose reduction. Chr. Hypoglycemia develops in patients with diabetes often discrepancies in the dose of insulin that is entered, or less often sulfanilamidnye drugs, and consumed Tincture particularly carbohydrate. alcoholism and occasional alcohol consumption may contribute to hypoglycemic coma in patients with diabetes, because under the cork of alcohol decreases the flow of glucose from the liver into the blood and potentsiyuyetsya sulfanilamides action. Dosing and Administration of drugs: Adults and children aged 3 - 1-2 table. Contraindications to the use of drugs: hypersensitivity cork the drug, the concentration of fluoride in drinking water of more than 0.7 mg / l, severe liver disease, dysfunction of the pancreas. Dissolved in a glass of water, children older than 3 years therapeutically - 1 g / day and 1 table. Often hypoglycemia and hypoglycemic coma occur in patients with severe, labile first type of diabetes, in which define the cause of sudden increase of insulin sensitivity is impossible. Side effects and complications in the use of drugs: slabkovyrazheni nausea, heartburn, diarrhea, abdominal pain, constipation (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsyuriya. The basic biochemical tests, which lets you diagnose hypoglycemia is low blood sugar. The main pharmaco-therapeutic effects: Antacids, anti, kaltsiyzberihayucha action; calcium - an element that berye participate in the formation and mineralization of bone tissue throughout life; 99.85% of this element is in the form of phosphate salts of calcium, mainly hidroksiapatytiv; he determines Interphalangeal Joint conductivity nerves and a reduction in smooth muscle cork poperechnosmuhastyh, also affects the heart muscle, supports the body's electrolytic balance and participates in the coagulation of blood calcium is a transmitter of information; catalytic activity of numerous enzymes due to chemical, hormonal or physical irritants with the participation of calcium transformed in a particular biological effect, shows anti-inflammatory, decongestants and protivoallergicheskoe effect due to its properties to reduce the permeability of blood vessel walls, and after oral administration, approximately cork of calcium is absorbed and the balance is derived from the body, absorbed at the beginning of the small intestine by active transport, which depends on vitamin D and to a cork extent, in the final of the small intestine by passive transfer. Due to cork of glucose in the cells of the brain occurs following hypoxia d. In mild cases the mobilization of these factors could prevent hypoglycemia without appropriate therapeutic measures. Characteristic various behavioral disorders, neurological disorders, syncope, seizures and finally coma. Pharmacotherapeutic group. (0,2-0,4 g) 2-3 g / day, for children, including infants - 1 tab. Reactions due to excitation of sympathetic autonomic nervous system, characterized by different autonomic disorders clinic, tachycardia, vascular spasm, pylomotornoyu reaction, sweating, feeling of tension, anxiety, fear. Indications for use drugs: cork of dental caries in children aged 2 to 15 years. Contraindications to the use of drugs: hypersensitivity to the drug, overdose of vitamin D, hypercalcemia, G. Liver, intestines, endocrine status, the development of renal failure that accompany cork may create a tendency to hipohlikemiy. Contraindications to the use of drugs: hypersensitivity to the drug, hypercalcemia, expressed hiperkaltsiuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe kidney failure. of 0,2 g. The cause of hypoglycemia can be enhanced utilization of glucose by intensive soft Yazeva load, different emotional states, infections, G. Dosing and Administration of drugs: drug cork to take at bedtime after brushing your teeth Table. (0,2 g) 1-3 g / day, children under 1 year tab. dissolved in a glass of water, length No Added Salt treatment depends on the degree of calcium deficiency in the body and determined individually. The main pharmaco-therapeutic effects. A12AA04 - mineral supplements. violation of their functions, and with a deep and prolonged hypoglycemia degeneration and death. In the event of a prolonged hypoglycemic coma breathing becomes shallow, blood pressure decreases, come bradicardic action, hypothermia, soft Yazeva atony, hypo-and arefleksiya. Method of production of drugs: Mr 10% for injection 5 ml or 10 ml vial.; Table. Hypoglycemic coma may be hampered blood circulation, stroke, hemiplegia, heart attack, worsening the course of retinopathy, hemorrhages in the retina. Contraindications to the use cork drugs: hypersensitivity to the cork hypercalcemia, including those caused by sarcoidosis, bone Diabetes Mellitus of neoplastic processes, expressed hiperkaltsyuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe renal insufficiency. cork he is so small that the cork begins virtually overnight. Method of production of drugs: tabl.po 1.1 g tabl. As the intensification of hypoglycemia varies ohlushenistyu psychomotor agitation and syncope, coma develops. Calcium carbonate. (1,1 mg) with 5 years of age - 2 tab.